Polyphenols from aerial parts of Polygonum bellardii and their biological activities

Pharm Biol. 2013 Aug;51(8):1026-34. doi: 10.3109/13880209.2013.775160. Epub 2013 Jun 14.

Abstract

Context: Polygonum species have been used in the treatment of several types of inflammatory disorders and cancer. Nevertheless, there are no reports related to the anti-inflammatory and anti-proliferative activities of Polygonum bellardii All. (Polygonaceae).

Objective: This study investigated the chemical composition of the methanol extract of P. bellardii. The anti-inflammatory and cytotoxic activities of methanol, n-butanol, ethyl acetate extracts and isolated polyphenols were determined.

Materials and methods: The chemical structure of the isolated compounds was elucidated using different spectral techniques. MTT assay was used to evaluate the anti-proliferative activity in HeLa, MCF-7 and HepG-2 cells. Inhibition of 5-lipoxygenase (5-LOX) activity and prostaglandin E2 (PGE2) production in stimulated HepG-2 cells were used to assess the anti-inflammatory activity.

Results: The present study resulted in isolation of five compounds (new for the species). They were identified as gallic acid (1), quercetin (2), myricetin (3), quercetin-3-O-β-D-glucopyranoside (5) and myricetin-3-O-α-arabinofuranoside (7). Additionally, a couple of previously isolated compounds such as quercetin-3-O-(5″-acetyl-α-arabinofuranoside) (4) and myricetin-3-O-(5″-acetyl-α-arabinofuranoside) (6) were detected. The n-butanol extract has the highest cytotoxicity in HeLa, MCF-7 and HepG-2 cells, with IC₅₀ values of 15.26, 50.66 and 30.09 µg/ml, respectively. Compound 6 exhibited a marked cytotoxicity in HeLa (IC₅₀ 75.04 µg/ml) and HepG-2 (IC₅₀ 41.03 µg/ml) cells. Crude extracts and pure compounds inhibited the 5-LOX activity and PGE2 production in a dose-dependent manner (0.1-250 µg/ml).

Discussion and conclusion: These results explain the traditional uses of P. bellardii and indicate that polyphenols, despite structural similarity, have different cytotoxic and anti-inflammatory effects.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Arachidonate 5-Lipoxygenase / drug effects
  • Arachidonate 5-Lipoxygenase / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology
  • Dinoprostone / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Inhibitory Concentration 50
  • Lipoxygenase Inhibitors / administration & dosage
  • Lipoxygenase Inhibitors / isolation & purification
  • Lipoxygenase Inhibitors / pharmacology
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology
  • MCF-7 Cells
  • Plant Components, Aerial
  • Plant Extracts / administration & dosage
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Polygonum / chemistry*
  • Polyphenols / administration & dosage
  • Polyphenols / isolation & purification
  • Polyphenols / pharmacology*
  • Solvents / chemistry
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / pathology

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents, Phytogenic
  • Lipoxygenase Inhibitors
  • Plant Extracts
  • Polyphenols
  • Solvents
  • Arachidonate 5-Lipoxygenase
  • Dinoprostone